Archive for: English

Diagonal Bio AB publish – White paper

, ,
Diagonal Bio’s platforms using an 8-parallel test format, show overall Accuracy of 99.6 %, Sensitivity of 100 %, and Specificity of 99.5 %.Diagonal Bio publishes its latest white paper describing the technology and specifications of its…

Diagonal Bio AB strengthens its go-to-market strategy through an agreement with founding partner Johan Källstrand

, ,
Diagonal Bio AB (publ) ("Diagonal Bio" or the "Company") today announces a strategic step to strengthen its sales and marketing efforts. The company has secured the commitment of Johan Källstrand, one of the company's founders with extensive…

The subscription period in Diagonal Bio AB rights issue commences today

, , ,
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION…

Diagonal Bio announces successful pilot study results and extended partnership with Hørsholm Veterinary Clinic

, , , ,
Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) announces the extension of its partnership with Hørsholm Veterinary Clinic following the successful completion of a three-month pilot study. The pilot study…

Diagonal Bio AB publishes a prospectus because of upcoming rights issue

, , ,
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION…

Bulletin from the Extraordinary General Meeting on Tuesday 2[nd] of April in Diagonal Bio AB

, , ,
Today, 2[nd] April 2024, an Extraordinary General Meeting was held in Diagonal Bio AB, reg. no. 559248–8984. Below is a summary of the resolutions passed. All resolutions were passed with the required majority.The board's proposal on reducing…

Diagonal Bio appoints Karin Wehlin as new CEO

, , , ,
Diagonal Bio AB (publ.) (“Diagonal Bio” or “the Company”) is pleased to announce that the Board of Directors has appointed Karin Wehlin as Chief Executive Officer (CEO) of Diagonal Bio. Karin Wehlin is currently Diagonal…

Notice to attend the extraordinary general meeting of Diagonal Bio AB

, , ,
Shareholders in Diagonal Bio AB, 559248-8984, are hereby invited to attend an extraordinary general meeting on Tuesday, 2nd of April, 2024, at 13:00 CET at The Spark, conference room 10, Medicon Village, Scheeletorget 1 Lund.Right to Participate…

The Board of Directors decides on a preferential rights issue of units in order to finance future development

, , , ,
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION…

Diagonal Bio AB Year-end Report 2023

, , , , , ,
“Looking back at 2023, I am proud to point out the significant steps we have made in our development, including the key achievements such as the CE-marking of LAMPlify® according to Low Voltage Directive (LVD) 2006/95/ EC. A highlight…